Drug interactions
Buprenorphine subdermal implant + Cariprazine
Severity: Moderate
Buprenorphine subdermal implant and Cariprazine: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Both drugs depress the central nervous system, so combined use can cause greater drowsiness, impaired psychomotor performance and, in more severe cases, respiratory depression. Opioids given with other CNS depressants carry a labeled warning for profound sedation and respiratory depression.
What this interaction means in plain words
Buprenorphine subdermal implant and Cariprazine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Additive central nervous system depression from opioid receptor agonism and antipsychotic sedative effects.
What to do
Reserve the combination for patients without adequate alternatives and monitor for sedation and respiratory depression, especially after dose changes. Counsel patients to avoid driving and alcohol.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Buprenorphine subdermal implant and Cariprazine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Cariprazine
Frequently asked questions
Can I take Buprenorphine subdermal implant with Cariprazine?
MediHelp rates the interaction as moderate. Buprenorphine subdermal implant and Cariprazine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs depress the central nervous system, so combined use can cause greater drowsiness, impaired psychomotor performance and, in more severe cases, respiratory depression. Opioids given with other CNS depressants carry a labeled warning for profound sedation and respiratory depression.
How serious is the interaction between Buprenorphine subdermal implant and Cariprazine?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Reserve the combination for patients without adequate alternatives and monitor for sedation and respiratory depression, especially after dose changes. Counsel patients to avoid driving and alcohol.
What other medicines interact with Cariprazine?
MediHelp also lists interactions of Cariprazine with, for example, Alfentanil, Amisulpride, Amobarbital. The full list is on the Cariprazine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
